SREBP1, upregulated by IDH1R132H, enhances p21 expression (independent of the p53 signaling pathway) and inhibits phosphorylation of retinoblastoma protein, thereby slowing cell cycle progression in glioma cells (Miyata et al., 2013). This evidence concerns the gene SREBF1 and central nervous system cancer.